Filing Details

Accession Number:
0000711377-14-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-27 18:02:44
Reporting Period:
2014-08-25
Filing Date:
2014-08-27
Accepted Time:
2014-08-27 18:02:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-25 7,198 $13.04 189,728 No 4 M Direct
Common Stock Disposition 2014-08-25 7,198 $43.39 182,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2014-08-25 7,198 $0.00 7,198 $13.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
130,038 2014-08-29 No 4 M Direct
Footnotes
  1. Options were granted on 8/24/2009, vest in equal annual installments on the anniversary date of the grant, and have five year lives.